We serve Chemical Name:2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane CAS:2374-14-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane
CAS.NO:2374-14-3
Synonyms:1,3,5-Tris(3,3,3-trifluoropropyl)-1,3,5-trimethylcyclotrisiloxane;MFCD00240602;Fluorosilicone cyclic trimer;Cyclotrisiloxane, 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-;2,4,6-Trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane;Silicone fluid;1,3,5-Tris[(3,3,3-trifluoropropyl)methyl]cyclotrisiloxane;EINECS 219-154-7;Fluorosilicone trimer;B071 CUT II
Molecular Formula:C12H21F9O3Si3
Molecular Weight:468.535
HS Code:2903399090
Physical and Chemical Properties:
Melting point:35°C
Boiling point:253.5±35.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.381
PSA:27.69000
Exact Mass:468.065491
LogP:6.12300
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:2811
Packing Group:II
Contact us for information like 1,3,5-Tris(3,3,3-trifluoropropyl)-1,3,5-trimethylcyclotrisiloxane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,B071 CUT II physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Silicone fluid Use and application,1,3,5-Tris[(3,3,3-trifluoropropyl)methyl]cyclotrisiloxane technical grade,usp/ep/jp grade.
Related News: Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane manufacturer Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane supplier ��The number of confirmed cases of coronavirus in Taiwan is not higher than in most countries affected,�� Mr. Wu said. ��Other than China, no other country, no other country has had its flight banned by Italy.�� 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane vendor For example, people who go to indoor concerts, sporting events or other large gatherings for more than 5,000 people will have to provide proof of vaccination or a recent negative COVID-19 test, and those who go to outdoor events with more than 10,000 people are strongly encouraged” to do the same, the AP reported.
Lovers of Mickey Mouse, rejoice: Starting Tuesday, face masks will be optional for visitors to Walt Disney World in Florida who are fully vaccinated against COVID-19.
Face masks will still be required indoors and on all attractions for visitors who aren’t fully vaccinated, as well as children under age 12. Vaccines aren’t yet available for that age group.
All visitors, fully vaccinated or not, will still have to wear face coverings on buses, monorails and Disney Skyliner, the resort’s aerial gondola, CBS News reported.
Last month, the theme park started allowing visitors to go mask-free outdoors. An easing of physical distancing guidelines is expected in the near future, park officials said.
Disney World closed for two months last year at the start of the outbreak and reopened last summer with strict safety guidelines that involved masking, social distancing and crowd limits.
“It’s important to remember that some experiences and entertainment may still be operating with limited capacity or may remain temporarily unavailable,” the company said on its website. “We’re not quite ready to bring back everything yet, but we are optimistic and look forward to the day when Disney pals and princesses are able to hug once again. 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane factory Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection.
Lovers of Mickey Mouse, rejoice: Starting Tuesday, face masks will be optional for visitors to Walt Disney World in Florida who are fully vaccinated against COVID-19.
Face masks will still be required indoors and on all attractions for visitors who aren’t fully vaccinated, as well as children under age 12. Vaccines aren’t yet available for that age group.
All visitors, fully vaccinated or not, will still have to wear face coverings on buses, monorails and Disney Skyliner, the resort’s aerial gondola, CBS News reported.
Last month, the theme park started allowing visitors to go mask-free outdoors. An easing of physical distancing guidelines is expected in the near future, park officials said.
Disney World closed for two months last year at the start of the outbreak and reopened last summer with strict safety guidelines that involved masking, social distancing and crowd limits.
“It’s important to remember that some experiences and entertainment may still be operating with limited capacity or may remain temporarily unavailable,” the company said on its website. “We’re not quite ready to bring back everything yet, but we are optimistic and look forward to the day when Disney pals and princesses are able to hug once again. 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane factory Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection.
